Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.22.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock.
Private Placement
Common Stock.
Additional Paid-in Capital
Private Placement
Additional Paid-in Capital
Accumulated Deficit
Convertible preferred stock (as converted to common stock)
Private Placement
Total
Balance at the beginning at Dec. 31, 2019           $ 72,883    
Balance at the beginning (in shares) at Dec. 31, 2019           74,133,667    
Convertible Preferred Stock                
Issuance of Series B-1 convertible preferred stock, net of issuance costs of $105           $ 2,994    
Issuance of Series B-1 convertible preferred stock, net of issuance costs of $105 (in shares)           3,206,390    
Balance at the end at Dec. 31, 2020           $ 75,877   $ 75,877
Balance at the end (in shares) at Dec. 31, 2020           77,340,057   77,340,057
Balance at the beginning at Dec. 31, 2019   $ 1   $ 7,978 $ (66,489)     $ (58,510)
Balance at the beginning (in shares) at Dec. 31, 2019   8,624,009            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of warrants to purchase common stock       112       112
Issuance of common stock upon exercise of stock options       442       442
Issuance of common stock upon exercise of stock options (in shares)   1,222,821            
Stock-based compensation expense       662       662
Net loss         (27,392)     (27,392)
Balance at the end at Dec. 31, 2020   $ 1   9,194 (93,881)     $ (84,686)
Balance at the end (in shares) at Dec. 31, 2020   9,846,830            
Convertible Preferred Stock                
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger           $ (75,877)    
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger           (77,340,057)    
Balance at the end (in shares) at Dec. 31, 2021               0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger   $ 8   75,869       $ 75,877
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger (in shares)   80,833,007            
Issuance of common stock in connection with the closing of the Merger   $ 1   84,944       $ 84,945
Issuance of common stock in connection with the closing of the Merger (in shares)   10,391,513           10,391,513
Issuance of public warrants in connection with the closing of the Merger       (23,636)       $ (23,636)
Issuance of common stock in connection with the consummation of the PIPE Investment $ 3   $ 299,997       $ 300,000  
Issuance of common stock in connection with the consummation of the PIPE Investment (in shares) 30,000,000              
Issuance of common stock for net settlement of common stock and preferred stock warrants upon settlement of the Merger       880       880
Issuance of common stock for net settlement of common stock and preferred stock warrants upon settlement of the Merger (in shares)   2,029,712            
Issuance of common stock for the conversion of convertible notes   $ 1   53,644       53,645
Issuance of common stock for the conversion of convertible notes (in shares)   5,408,672            
Issuance of warrants to purchase common stock       1       1
Payment of deferred offering costs in connection with the closing of the Merger and PIPE Investment     $ (36,065)       $ (36,065)  
Initial fair value of contingent earn-out liability recognized upon the closing of the Merger       (67,021)       (67,021)
Initial fair value of contingently issuable common stock liability recognized upon the closing of the Merger       (11,670)       (11,670)
Issuance of common stock upon exercise of stock options       915       $ 915
Issuance of common stock upon exercise of stock options (in shares)   4,276,327           2,806,961
Repurchase of common stock upon settlement of related party note (in shares)   (43,665)            
Issuance of common stock upon vesting of restricted stock units (in shares)   2,625            
Stock-based compensation expense       8,511       $ 8,511
Net loss         (10,858)     (10,858)
Balance at the end at Dec. 31, 2021   $ 14   $ 395,563 $ (104,739)     $ 290,838
Balance at the end (in shares) at Dec. 31, 2021   142,745,021